HopeStage
Back to all studies
UnknownNCT06399523

A Study to Evaluate the Efficacy of VR for Bipolarity

Device studyAges 13+China
The study in practice

Understand this study

Who could participate?

Listed age limits: from 13 years.

Listed locations
ShanghaiSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: March 4, 2024
Recruitment status
Unknown
Enrollment listed in the registry
48
Sponsor
Shanghai Mental Health Center
Sponsor type
Hospital / academic medical center
Study type
Device
Intervention type
Device
Locations
China
Age range
Over 13 Years
Official registry ID
NCT06399523
Official title
Show the full official title

A Prospective, Randomized Controlled Clinical Trial to Evaluate the Efficacy of VR for Bipolar Disorder

Recruitment & locations

Status unknown

Shanghai

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Shanghai Mental Health Center, a hospital or academic medical center.

Who can participate?

Listed age limits: from 13 years.

Want to explore more studies?

Explore studies